Other Income & Expense
Other Income (Expense)
Albemarle Other Income (Expense) increased by 86.8% to $53.81M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 425.0%, from $10.25M to $53.81M. Over 2 years (FY 2021 to FY 2024), Other Income (Expense) shows an upward trend with a -46.9% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Detailed definition
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Peer comparison
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
Metric ID:
other_income_expense_netHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.00K | -$643.20M | $0.00 | $15.50M | $8.77M | $7.97M | $54.12M | $82.49M | $53.95M | $11.18M | $49.90M | $33.67M | -$22.26M | $117.03M | $10.25M | -$6.56M | $28.80M | $53.81M |
| QoQ Change | — | <-999% | +100.0% | — | -43.4% | -9.0% | +578.7% | +52.4% | -34.6% | -79.3% | +346.3% | -32.5% | -166.1% | +625.8% | -91.2% | -164.0% | +539.1% | +86.8% |
| YoY Change | — | — | — | — | >999% | +101.2% | — | +432.3% | +515.4% | +40.2% | -39.5% | -37.6% | -299.0% | — | -79.5% | -119.5% | +229.4% | +425.0% |
Range-$643.20M – $117.03M
CAGR+597.4%
Avg YoY Growth>999%
Median YoY Growth+70.7%
Current Streak2 quarters growth
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Albemarle's other income (expense)?
- Albemarle (ALB) reported other income (expense) of $53.81M in Q1 2026.
- How has Albemarle's other income (expense) changed year-over-year?
- Albemarle's other income (expense) increased by 425.0% year-over-year, from $10.25M to $53.81M.
- What is the long-term trend for Albemarle's other income (expense)?
- Over 2 years (2021 to 2024), Albemarle's other income (expense) has grown at a -46.9% compound annual growth rate (CAGR), from -$631.87M to $178.34M.
- What does other income (expense) mean?
- The net result of all income and expenses not related to core business operations.